X. Duportet

Most-cited papers

1. Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases

   D. Bikard, C. Euler, Wenyan Jiang, P. Nussenzweig +4 more

   2014Nature Biotechnology827 citations Open access

   Semantic Scholar

   Save

2. A platform for rapid prototyping of synthetic gene networks in mammalian cells

   X. Duportet, Liliana Wroblewska, P. Guye, Yin-Qing Li +5 more

   2014Nucleic Acids Research150 citations Open access

   Semantic Scholar

   Save

3. In situ targeted base editing of bacteria in the mouse gut

   Andreas K. Brödel, Loïc H. Charpenay, M. Galtier, Fabien J. Fuche +13 more

   2024Nature118 citations Open access

   Semantic Scholar

   Save

4. The biological interpretation of metabolomic data can be misled by the extraction method used

   X. Duportet, R. Aggio, Sónia Carneiro, S. Villas-Bôas

   2012Metabolomics101 citations Open access

   Semantic Scholar

   Save

5. Rapid, modular and reliable construction of complex mammalian gene circuits

   P. Guye, Yin-Qing Li, Liliana Wroblewska, X. Duportet +1 more

   2013Nucleic Acids Research91 citations Open access

   Semantic Scholar

   Save

6. Comparison of Integrases Identifies Bxb1-GA Mutant as the Most Efficient Site-Specific Integrase System in Mammalian Cells.

   Barbara Jusiak, Kalpana Jagtap, L. Gaidukov, X. Duportet +5 more

   2019ACS Synthetic Biology52 citations

   Semantic Scholar

   Save

7. Design and connection of robust genetic circuits.

   A. Randall, P. Guye, Saurabh Gupta, X. Duportet +1 more

   2011Methods in Enzymology31 citations

   Semantic Scholar

   Save

8. CRISPR–Cas therapies targeting bacteria

   F. Benz, Beatriz Beamud, Raphael Laurenceau, A. Maire +3 more

   2025Nature Reviews Bioengineering22 citations Open access

   Semantic Scholar

   Save

9. In situ targeted mutagenesis of gut bacteria

   Andreas K. Brödel, Loïc H. Charpenay, M. Galtier, Fabien J. Fuche +9 more

   2022bioRxiv7 citations Open access

   Semantic Scholar

   Save

10. Treatment of Shiga toxin-producing E. coli infection by CRISPR-Cas-targeted cleavage of the Shiga toxin gene in animal models.

    M. Galtier, A. Krawczyk, Fabien J. Fuche, Loïc H. Charpenay +25 more

    2026Science Translational Medicine4 citations

    Semantic Scholar

    Save

11. Treatment of STEC infection via CRISPR-Cas targeted cleavage of the Shiga toxin gene in animal models

    M. Galtier, A. Krawczyk, Fabien J. Fuche, Loïc H. Charpenay +25 more

    2025bioRxiv3 citations Open access

    Semantic Scholar

    Save

12. Voices of biotech leaders

    Katrine S. Bosley, Charlotte Casebourn, Priscilla Chan, Janice Chen +34 more

    2021Nature Biotechnology3 citations Open access

    Semantic Scholar

    Save

13. Developing new tools and platforms for mammalian synthetic biology : From the assembly and chromosomal integration of complex dna circuits to the engineering of artificial intercellular communication systems

    X. Duportet

    20141 citations

    Semantic Scholar

    Save

14. Publisher Correction: Voices of biotech leaders

    Katrine S. Bosley, Charlotte Casebourn, Priscilla Chan, Janice Chen +34 more

    2021Nature Biotechnology0 citations Open access

    Semantic Scholar

    Save

15. The biological interpretation of metabolomic data can be misled by the extraction method used

    X. Duportet, R. Aggio, Sónia Carneiro, S. Villas-Bôas

    2011Metabolomics0 citations Open access

    Semantic Scholar

    Save

16. Is the biological interpretation of metabolomic data misled by the extraction method performed

    X. Duportet, S. Villas-Bôas, R. Aggio, Sónia Carneiro

    20090 citations

    Semantic Scholar

    Save